Newsletter

BioMedSA’s Board of Directors approved 2 new memberships in May 2023: iGenomeDX and Aiculus. iGenomeDx is a San Antonio based molecular diagnostic laboratory whose mission is to enhance decision-making for physicians, increase the quality of care for patients, and lower the costs of healthcare for everyone by providing reliable genetic testing services. Testing services in … Read more

The potential for tremendous growth in Bioscience Artificial intelligence (AI) is staggering with some areas expected to grow as much as 40% Compounded Annual Growth Rate (CAGR) over the next 10 years.  Potential areas of growth include: 1). Drug Discovery, 2). Genomics, 3). Medical Imaging, 4). Precision Medicine, 5). Synthetic Biology and 6). Robotics and … Read more

Biofest Invest 2023 was held on April 19, 2023, the day before the start of San Antonio’s Fiesta celebration. Over 260 people registered to attend.  Medtech, biotech, digital health, and pharma entrepreneurs made connections with investors, support organizations, and colleagues, as well as received helpful information to enable their growth.  Forty-nine sponsors across the life science … Read more

The U.S. Small Business Administration (SBA) announced San Antonio’s BioMedSA as a Stage One winner for the 2023 Growth Accelerator Fund Competition. BioMedSA will receive a $50,000 cash prize to build strategic partnerships that will support the launch, growth, and scale of bioscience startups in San Antonio and the surrounding region, serving as a model for … Read more

Bexar County Commissioners presented Heather Hanson, President of BioMedSA, a proclamation of Biofest Week. Biofest Week is a chance to celebrate San Antonio’s largest economic sector, healthcare and bioscience during the week before Fiesta. Biofest Week was started with Biofest Invest in person for the first time in 2022. Biofest Invest connects bioscience entrepreneurs with … Read more

BioMedSA’s Board of Directors approved 4 new memberships in March 2023: NewLife Medicals, Harness IP, Fukuda Denish, and Nixon Peabody. NewLife Medicals (USA), Inc. supplies Reference Listed Drugs (RLDs) to large multinational companies, Clinical Research Organizations (CROs) and clinical trial sponsors. Their US FDA registered, GDP compliant warehouse provides storage & distribution facilities.  Their storage … Read more

BioMedSA’s Board of Directors approved 5 new memberships in February 2023: Parsons, Camber Road, SygnaMap, Adverse Machine and Fabrication, and Fun And Moving. Parsons Corporation is focused on creating the future of the defense, intelligence, and critical infrastructure markets. The company has deep domain expertise in Life Sciences and Biodefense, drawing on proven, best-in-class resources … Read more

BioMedSA’s Board of Directors approved 6 new memberships in January 2023: Advanced TeleSensors Inc., RegenTX Labs, Savidj, SCIE Solutions, and two individual members Edward Shipper, and Tewodros Gashu. Advanced TeleSensors Inc. is a startup out of Austin, TX, that has developed a touchless vital signs monitoring device called Cardi/o. Cardi/o is designed to monitor a … Read more

So you want to sell your product to the federal marketplace: now what? The federal marketplace for healthcare and bioscience products is a large ecosystem. There are local, regional, and national systems, a variety of contract vehicles used, and plenty of federal stakeholders involved in the process. There is no single pathway that represents how … Read more

Jean Jiang currently studies gap junctions in cell membranes that facilitate cell-to-cell messages and ion travel. She has developed antibody therapeutics that target neuro-inflammatory injuries for reductions in local inflammation and scarring. This mechanism enables neurons to regenerate and improve recovery from spinal cord injury. She has also developed an antibody therapeutic for breast cancer … Read more